Bookbuilding IPO | ₹60 Cr | Listing at BSE, NSE | Mon, Mar 29, 2004 - Wed, Apr 7, 2004P
The allotment status for the DISHMAN PHARMACEUTICALS CHEMICALS IPO is currently not available. The allotment details will be published once the basis of allotment is finalized. Investors are advised to revisit this page regularly to stay updated with the latest allotment status, subscription details, and further announcements related to the DISHMAN PHARMACEUTICALS CHEMICALS IPO.
Sorry. The tentative date of allotment for DISHMAN PHARMACEUTICALS CHEMICALS IPO is not available at this time.
Below are the steps to check Dishman Pharmaceuticals & Chemicals Ltd. IPO allotment status online:
Note: The disabled button shows that the allotment is not yet available online.
The allotment result looks like as below:
The expected Listing price of DISHMAN PHARMACEUTICALS CHEMICALS IPO depends on many factors including demand, nature of the business, market environment, and state of the economy. The DISHMAN PHARMACEUTICALS CHEMICALS IPO grey market premium gives some hint but the actual Listing price is difficult to guess.
Dishman Pharmaceuticals & Chemicals Ltd. IPO IPO allotment status is expected on [.]. Click the green button Dishman Pharmaceuticals & Chemicals Ltd. IPO allotment status above to check the allotment. Note : The button remains disabled until the allotment is available online.
If DISHMAN PHARMACEUTICALS CHEMICALS IPO oversubscribed in the retail category, the DISHMAN PHARMACEUTICALS CHEMICALS IPO shares will be distributed on a proportionate basis to Retail Individual Investors (RII). Each retail investor will get a minimum of 1 lot subject to the availability of shares in the retail portion. If enough shares are not available, a lottery is drawn to choose the investors.
The Dishman Pharmaceuticals & Chemicals Ltd. listing date is not yet announced. The DISHMAN PHARMACEUTICALS CHEMICALS IPO is planned to list on [.], at BSE, NSE.
The reason you didn't get the DISHMAN PHARMACEUTICALS CHEMICALS IPO could be:
| IPO Details |
| IPO Recommendations |
| IPO Live Subscription |
| IPO FAQs |